Volume | 0 |
|
|||||
News | - |
Etf Name | Etf Symbol | Market | Stock Type |
---|---|---|---|
BNP Paribas Asset Management Luxembourg | ASRT | Tradegate | Exchange Traded Fund |
Price Change | Price Change % | Etf Price | Last Trade | |
---|---|---|---|---|
0.00 | 0.00% | 9.0637 | 06:12:47 |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
9.0637 |
Trades | Etfs Traded | Average Volume |
---|---|---|
0 | 0 | - |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | 9.0637 | EUR |
News BNP Paribas Asset Manage...
Forum BNP Paribas Asset Manage...
Date | Time | Comments | Title |
---|---|---|---|
5/15/2024 | 04:04 | - | Rolvedon/eflapegrastim is a new molecule. You cannot call |
5/14/2024 | 15:54 | - | dcaf7, please elaborate on what you mean? |
5/14/2024 | 05:01 | - | Listened to yesterday ASRT presentation. They call Rolvedon |
3/18/2024 | 04:25 | - | Rolvedon pediatric study is a postmarketing requirement from |
3/17/2024 | 04:11 | - | A couple questions. A few days ago, a |
3/16/2024 | 05:34 | - | ASRT.........................https://stockcharts.com/h-sc/ui?s=ASRT&p=W&b=5&g=0& |
3/10/2024 | 08:39 | - | ASRT 10Q due March 11 |
3/03/2024 | 12:36 | - | I don’t have an answer about what does |
3/02/2024 | 06:26 | - | The same day dosing trial for R has |
2/14/2024 | 06:39 | - | Hanmi Pharma said it has signed a strategic |
ASRT Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |